"A dynamic organisation
with enthusiastic and
dedicated people"

> Read more about our Team spirit

"A knowledge driven company"

> Read more about our dynamic company

"Innovation - It`s about
improvement through
creativity, invention
and initiative"

> Read more about PHARMAQ innovation

"We care about the fish,
from egg to table"

> Read more about PHARMAQ quality

Point, click and open your region of interest

Pharmaq Achievements

1987

We launched the first vaccine ever against cold water vibriosis - "saving" the Norwegian salmon industry and dramatically reduced the use of antibiotics

1991

Introduction of the world's first oil based fish vaccine offering protection against furunculosis

1996

Our State-of-the-art GMP production facility for fish vaccines opens in Overhalla, Norway

1997

The first six component vaccine ever introduced in Norway. Includes protection against IPNV and winter ulcer.

1998

ALPHA MAX® for bath treatment against salmon lice available in the Norwegian- and the Faroese market

2001

Established office in Puerto Montt, Chile, later to become PHARMAQ AS Chile Ltda.

2002

The first European fish vaccine ever approved by the Canadian authorities

2004

Obtained approval in UK for the first virus vaccine for fish - protection against IPNV and furunculosis

2004

PHARMAQ established 23 July by 'management buy out' of the Aquatic Animal Health business of Alpharma Inc.

2007

Launch of our first generation SRS vaccine in Chile

2008

MA approved for ALPHA JECT micro® 6 in Norway, the first six-component micro dose vaccine available

2008

Sales license for ALPHA JECT® micro 3 in Chile, the first trivalent SRS micro dose vaccine available

2008

PHARMAQ opened office in Vietnam, later to become PHARMAQ Ltd. VN

2008

Acquisition of PHARMAQ by Orkla and Kverva

2009

Extensive field trial of the first Pangasius vaccine started in Vietnam

2010

PHARMAQ's first ISA vaccine received a provisional marketing authorisation from the Chilean authorities

2011

PHARMAQ officially opened its PHARMAQ Turkey Ltd office in Izmir in May

2011

PHARMAQ signed a long term agreement with Norwegian Institute of Public Health for lease of virus antigen production facilities in Norway

2011

As the first fish vaccine commercially available in Vietnam, ALPHA JECT Panga 1 received a observation license

2012

PHARMAQ Holding acquires Havbruksinstituttet AS, renamed as PHARMAQ Analytiq

2013

Permira acquired PHARMAQ May 2013

2014

PHARMAQ and The Ministry of Agriculture and Rural Development in Vietnam signed agreement of co-operation

Future

We make aquaculture progress!